Kazia Therapeutics Limited (KZIA) Financials

$8.91

$0.42 (-4.5%)
Last update: 04:00 PM EST
Day's range
$8.9
Day's range
$9.44
$20M$20M$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30MEarning201820182019201920202020202120212022202220232023202420240%0%-20000000%-20000000%-40000000%-40000000%-60000000%-60000000%-80000000%-80000000%-100000000%-100000000%Profit Margin
Profit Margin
Revenue
Earnings

KZIA Income statement / Annual

Last year (2024), Kazia Therapeutics Limited's total revenue was $2.31 M, an increase of 415,755.86% from the previous year. In 2024, Kazia Therapeutics Limited's net income was -$26.78 M. See Kazia Therapeutics Limited,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015
Operating Revenue $2.31 M $555.00 $25.00 $15.18 M $1.06 K $1.57 K $13.11 K $8.79 M $4.07 M $89.00 K
Cost of Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $2.31 M $555.00 $25.00 $15.18 M $1.06 K $1.57 K $13.11 K $8.79 M $4.07 M $89.00 K
Gross Profit Ratio 1 1 1 1 1 1 1 1 1 1
Research and Development Expenses $17.38 M $15.56 M $20.25 M $14.54 M $9.49 M $6.48 M $9.77 M $11.14 M $9.89 M $5.94 M
General & Administrative Expenses $13.56 M $8.58 M $4.51 M $7.02 M $3.69 M $3.79 M $5.60 M $8.53 M $5.76 M $3.84 M
Selling & Marketing Expenses $0.00 $0.00 $127.04 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $13.56 M $8.58 M $4.64 M $7.02 M $3.69 M $3.79 M $5.60 M $8.53 M $5.76 M $3.84 M
Other Expenses -$28.64 M -$22.56 K -$10.00 K $0.00 -$22.00 K -$9.00 K $3.67 M $0.00 $2.87 M $1.54 M
Operating Expenses $2.31 M $24.12 M $24.88 M $24.13 M $13.16 M $10.25 M $14.69 M $19.66 M $15.64 M $9.68 M
Cost And Expenses $2.31 M $24.12 M $24.88 M $24.13 M $13.16 M $10.25 M $14.69 M $19.66 M $15.64 M $9.68 M
Interest Income $12.00 K $22.56 K $2.09 K $42.24 K $66.00 K $100.00 K $119.00 K $276.00 $406.00 K $89.26 K
Interest Expense $0.00 $0.00 $2.09 K $0.00 $0.00 $2.19 M $0.00 $0.00 $0.00 $68.62 K
Depreciation & Amortization $1.87 M $1.87 M $1.87 M $1.27 M $1.08 M $1.08 M $1.55 M $1.41 M $642.64 K $574.96 K
EBITDA -$26.77 M -$22.28 M -$23.51 M -$5.11 M -$11.11 M -$7.71 M -$10.82 M -$9.44 M -$11.72 M -$7.48 M
EBITDA Ratio -11.6 -40138.86 -940592.36 -0.34 -10470.77 -4927.16 -825.07 -1.07 -2.88 -84.02
Operating Income Ratio 0 -43466.61 -1067853.08 -0.42 -11804.9 -5354.63 -952.62 -1.23 -3.14 -91.47
Total Other Income/Expenses Net -$27.05 M $3.39 M $0.00 -$2.53 M -$569.58 K -$1.75 M $6.02 M $7.87 K $227.97 K $754.79 K
Income Before Tax -$27.05 M -$20.74 M -$25.02 M -$8.91 M -$12.77 M -$10.57 M -$6.34 M -$10.87 M -$12.16 M -$7.31 M
Income Before Tax Ratio -11.72 -37362.65 -1000635.8 -0.59 -12031.1 -6752.72 -483.98 -1.24 -2.99 -82.09
Income Tax Expense -$271.00 K $271.09 K -$368.08 K $484.35 K -$298.00 K -$298.00 K -$305.00 K $198.54 K $2.77 M $1.44 M
Net Income -$26.78 M -$20.47 M -$24.65 M -$8.42 M -$12.47 M -$10.27 M -$6.04 M -$10.67 M -$12.06 M -$7.14 M
Net Income Ratio -11.6 -36874.2 -985912.6 -0.55 -11750.24 -6562.3 -460.71 -1.21 -2.96 -80.21
EPS -55.85 -55.55 -93.05 -35.8 -81.75 -85.6 -59.8 -109.3 -135.2 -143.45
EPS Diluted -55.85 -55.55 -93.05 -35.8 -81.75 -85.6 -59.8 -109.3 -135.2 -143.45
Weighted Average Shares Out $479.60 K $368.60 K $265.00 K $235.40 K $152.46 K $120.01 K $100.96 K $97.63 K $89.20 K $49.76 K
Weighted Average Shares Out Diluted $479.60 K $368.60 K $265.00 K $235.40 K $152.46 K $120.01 K $100.96 K $97.63 K $89.20 K $49.76 K
Link